Tetrindole
Systematic (IUPAC) name | |
---|---|
2,3,3a,4,5,6-Hexahydro-8-cyclohexyl-1H-pyrazino[3,2,1-j,k]carbazole | |
Identifiers | |
ATC code | None |
PubChem | CID 160020 |
ChemSpider | 140675 |
ChEBI | CHEBI:77799 |
Chemical data | |
Formula | C20H26N2 |
Molar mass | 294.43 g/mol |
| |
| |
(what is this?) (verify) |
Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.[2]
References
- ↑ Medvedev, AE; Kirkel, AA; Kamyshanskaya, NS; Moskvitina, TA; Axenova, LN; Gorkin, VZ; Andreeva, NI; Golovina, SM; Mashkovsky, MD (20 January 1994). "Monoamine Oxidase Inhibition by Novel Antidepressant Tetrindole". Biochemical Pharmacology 47 (2): 303–8. doi:10.1016/0006-2952(94)90021-3. PMID 8304974.
- ↑ Ramsay, RR; Gravestock, MB (March 2003). "Monoamine Oxidases: to Inhibit or Not to Inhibit". Mini Reviews in Medicinal Chemistry 3 (2): 129–36. PMID 12570845.
|
This article is issued from Wikipedia - version of the Friday, January 08, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.